Advertisement
Screener

Verastem, Inc. (VSTM) Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss

2.2 / 5 stars · 29/66 Roast Me

Verastem, Inc. Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss

Verastem, Inc. (VSTM) had Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss of $7.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-07.

Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss

us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss · last filed 2026-05-07

  • 2026-03-31: Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss $7.00K.
  • 2024-03-31: Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss $4.00K.
  • 2023-12-31: Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss $1.00K.
  • 2022-12-31: Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss $2.00K.
Period endDebt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss
2026-03-31$7.00K
10-Q · filed 2026-05-07
2024-03-31$4.00K
10-Q · filed 2024-05-09
2023-12-31$1.00K
10-K · filed 2025-03-20
2022-12-31$2.00K
10-K · filed 2024-03-14
2018-09-30$2.00K
10-Q · filed 2018-11-07
2017-12-31$2.00K
10-Q · filed 2018-11-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nuvectis Pharma, Inc. (NVCT)United States$0.705B-17.53
IRONWOOD PHARMACEUTICALS INC (IRWD)United States$0.694B5.37
Climb Bio, Inc. (CLYM)United States$0.683B-13.03
COLLEGIUM PHARMACEUTICAL, INC (COLL)United States$0.737B24.57
ZEVRA THERAPEUTICS, INC. (ZVRA)United States$0.668B14.61
Faeth Therapeutics, Inc. (FTH)United States$0.750B
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78
Shattuck Labs, Inc. (STTK)United States$0.634B-13.30
Wave Life Sciences, Inc. (WVE)$0.780B-5.56